C Berr

Author PubWeight™ 78.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013 9.46
2 Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 2010 3.37
3 Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007 2.61
4 APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 2011 2.31
5 Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 2013 2.25
6 Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007 2.09
7 Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001 1.88
8 Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994 1.85
9 High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 2012 1.84
10 Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology 2009 1.70
11 Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000 1.57
12 Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008 1.56
13 Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 2009 1.51
14 Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology 2011 1.50
15 Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology 2011 1.48
16 Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry 2013 1.48
17 IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007 1.44
18 Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 1996 1.44
19 Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology 2009 1.41
20 Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 2011 1.28
21 Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry 2012 1.20
22 Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 1998 1.20
23 Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke 1996 1.17
24 Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A 2001 1.17
25 Ultrasonographic assessment of carotid wall characteristics and cognitive functions in a community sample of 59- to 71-year-olds. The EVA Study Group. Stroke 1996 1.15
26 Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999 1.14
27 Relationship between body mass index and different domains of disability in older persons: the 3C study. Int J Obes Relat Metab Disord 2004 1.12
28 Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994 1.12
29 How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050. Eur J Neurol 2009 1.10
30 Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology 2005 1.03
31 Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000 1.01
32 Cost of dementia in Europe. Eur J Neurol 2005 0.93
33 Validity of the free and cued selective reminding test in predicting dementia: the 3C study. Neurology 2010 0.92
34 Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr 2005 0.91
35 Sociodemographic differences in dietary habits in a population-based sample of elderly subjects: the 3C study. J Nutr Health Aging 2004 0.91
36 Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidase. Free Radic Biol Med 1996 0.87
37 Plasma insulin-like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality. Gerontology 2001 0.86
38 Impact of a premature menopause on cognitive function in later life. BJOG 2014 0.86
39 Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis 1996 0.85
40 [Benzodiazepine use in the elderly: the EVA Study]. Rev Epidemiol Sante Publique 2003 0.84
41 Occupational solvent exposure and cognition: does the association vary by level of education? Neurology 2012 0.84
42 Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry 2007 0.83
43 Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 1995 0.83
44 The renin angiotensin system and Alzheimer's disease. Ann N Y Acad Sci 2000 0.83
45 Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Artériel. Am J Clin Nutr 1997 0.82
46 VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 2001 0.82
47 A possible new genetic marker associated with a severe course of multiple sclerosis, located on chromosome 2: Km. N Engl J Med 1989 0.81
48 Hierarchical structure of the activities of daily living scale in dementia. J Nutr Health Aging 2014 0.81
49 Immunoglobulin allotypes and susceptibility to multiple sclerosis. An epidemiological and genetic study in the Hautes-Pyrénées county of France. J Neurol Sci 1986 0.80
50 Operational Definition of Active and Healthy Ageing (AHA): A Conceptual Framework. J Nutr Health Aging 2015 0.80
51 Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force). J Nutr Health Aging 2008 0.80
52 Orosomucoid: a mortality risk factor in elderly people living in the community? Clin Nutr 2002 0.79
53 Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly. Mol Psychiatry 2007 0.79
54 Early detection of patients in the pre demented stage of Alzheimer's disease: the Pre-Al Study. J Nutr Health Aging 2009 0.79
55 Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. The EVA Study Group. Neurobiol Aging 2000 0.78
56 [Proposed law on protection of personal rights concerning personal information. Position of the French National Civil Rights Commission (CCTIR)]. Rev Epidemiol Sante Publique 2003 0.77
57 Poor nutritional status is associated with a higher risk of falling and fracture in elderly people living at home in France: the Three-City cohort study. Osteoporos Int 2015 0.76
58 Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics 1999 0.76
59 Neurodegenerative dementia and parkinsonism. J Nutr Health Aging 2010 0.76
60 A simple score to predict survival with dementia in the general population. Neuroepidemiology 2013 0.76
61 Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study. J Epidemiol Community Health 1999 0.75
62 Viral antibody titers, immunogenetic markers, and their interrelations in multiple sclerosis patients and controls. Hum Immunol 1991 0.75
63 [Apolipoprotein E and Alzheimer disease]. Rev Neurol (Paris) 1995 0.75
64 MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing. J Frailty Aging 2016 0.75
65 [Risk factors of Alzheimer's disease. Epidemiologic approach]. Bull Acad Natl Med 1996 0.75
66 Loss of calcium-homeostatic mechanisms in polymorphonuclear leukocytes of demented and nondemented elderly subjects. Gerontology 1993 0.75
67 [Cohorts and biology databanks]. Rev Epidemiol Sante Publique 2003 0.75
68 Perception of Alzheimer's disease in the French population. J Nutr Health Aging 2014 0.75